Sublingual Semaglutide and Tirzepatide are now available! Get Started
Dashboard
Formulas

Estradiol 0.2 mg/Estriol 0.8 mg Slow Release (MEM4) Oral Capsules

The Estradiol 0.2 mg/Estriol 0.8 mg Slow Release (MEM4) Oral Capsules are a hormone replacement therapy (HRT) formulation designed to alleviate symptoms associated with menopause, such as hot flashes, vaginal dryness, and osteoporosis prevention. Each capsule contains a combination of estradiol and estriol hormones in a slow-release matrix using Methocel E4M, a controlled-release polymer. This advanced delivery system ensures a gradual release of the hormones over an extended period, which helps maintain consistent blood levels, minimizes the potential for side effects, and enhances patient adherence by reducing the frequency of dosing.

Want a different strength?
Click the Text Us button below.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Must be E-Prescribed
Get Started
Generate LeafletShow Leaflet
This medication requires a prescription from your doctor
Are you a prescriber? Sign Up
Trusted by 60,357 patients to date.
A group of faces of our past satisfied patients.
A svg symbol of a mortar and pestle with ingredients going in.
Custom made in our compounding labs.
Sliders that show the customization of ingredients.
Personalized treatment for better results.
User with a gear showing the personalization of the formulation.
All strengths and ingredients are tailored to your needs.
This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.
Slow Release Capsules
655ea7d4d2a91511c37d51d3
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Dosing Calculator

Get general dosing information for a patient by using this calculator.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Formula Information

A small arrow pointing down

The Estradiol 0.2 mg/Estriol 0.8 mg Slow Release (MEM4) Oral Capsules are a specialized hormone replacement therapy (HRT) designed to alleviate symptoms associated with menopause and other conditions caused by estrogen deficiency. This unique formulation combines two forms of estrogen: estradiol, the primary and most potent form of estrogen found in the body, and estriol, a weaker form of estrogen. The ratio of estradiol to estriol has been carefully selected to provide a balanced approach to estrogen therapy, aiming to minimize risks while maximizing benefits.

The capsules are formulated with Methocel E4M, a hydrophilic methylcellulose derivative that acts as a controlled-release polymer. This technology ensures that the active ingredients, estradiol and estriol, are released slowly and consistently into the bloodstream over an extended period. This slow-release mechanism mimics the body's natural release of hormones, leading to more stable hormone levels and reducing the incidence of peaks and troughs that can be associated with conventional hormone replacement therapies. The sustained release of hormones not only provides relief from menopausal symptoms such as hot flashes, night sweats, and vaginal dryness but also supports bone health, thereby reducing the risk of osteoporosis.

By reducing the dosing frequency, the Methocel E4M-based formulation enhances patient compliance, a critical factor in the long-term management of menopause symptoms and estrogen deficiency. Additionally, the controlled release of estrogen may potentially reduce the risk of endometrial hyperplasia, a concern with estrogen therapy that is often addressed by co-administering progesterone in women with an intact uterus.

It is important for both patients and prescribers to understand that hormone replacement therapy with estradiol and estriol should be tailored to the individual's needs and medical history. Regular monitoring and adjustments may be necessary to ensure optimal outcomes. Patients with a history of hormone-sensitive cancers, thromboembolic disorders, or unexplained vaginal bleeding should discuss the risks and benefits of HRT with their healthcare provider. As with any medication, adherence to prescribed dosing and routine follow-up appointments are essential for the safe and effective use of this therapy.

For further information or specific questions regarding the Estradiol 0.2 mg/Estriol 0.8 mg Slow Release (MEM4) Oral Capsules, or to discuss individual patient needs, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing comprehensive support and guidance to ensure the best possible outcomes for our patients and prescribers.

Drug Interactions

A small arrow pointing down

The Estradiol 0.2 mg/Estriol 0.8 mg Slow Release (MEM4) Oral Capsules are compounded with Methocel E4M, which is designed to provide a controlled release of the hormones estradiol and estriol over an extended period. This formulation is used in hormone replacement therapy to treat symptoms associated with menopause, such as hot flashes, vaginal dryness, and osteoporosis prevention. It is important to consider potential drug interactions when prescribing or taking this medication.

Estradiol and estriol are both forms of estrogen and can interact with a variety of medications. They may reduce the effectiveness of aromatase inhibitors (e.g., anastrozole, letrozole) which are used in the treatment of certain types of breast cancer. Concurrent use should be avoided or closely monitored. Estrogens can also interfere with the metabolism of drugs metabolized by cytochrome P450 enzymes, particularly CYP3A4. This can lead to either increased or decreased levels of drugs such as certain benzodiazepines, opioids, statins, and some anticonvulsants.

Thyroid hormone replacement therapy may require dose adjustments when taken with estrogens, as estrogens can increase thyroxine-binding globulin, thereby increasing the amount of thyroid hormone that is bound and inactive. Patients on thyroid replacement therapy should have their thyroid function monitored to ensure therapeutic levels are maintained.

Estrogens can also potentiate the effects of corticosteroids, so patients taking both may need a lower corticosteroid dose to avoid excessive effects. Additionally, estrogens can reduce the clearance of certain corticosteroids, leading to increased effects and potential side effects. Patients taking corticosteroids should be monitored for signs of excessive corticosteroid effects.

Patients on anticoagulant therapy, such as warfarin, should be closely monitored as estrogens can affect coagulation parameters. Estrogens may either potentiate or weaken the effects of anticoagulants, necessitating dose adjustments to maintain the desired anticoagulant effect and minimize the risk of bleeding or thrombosis.

Some herbal supplements, such as St. John's Wort, can induce the metabolism of estrogens, potentially reducing their effectiveness. Conversely, grapefruit juice can inhibit the metabolism of estrogens, potentially increasing their levels and risk of side effects. Patients should discuss the use of any herbal supplements or dietary habits with their healthcare provider.

It is also important to note that smoking can reduce the efficacy of estrogen therapy and increase the risk of cardiovascular side effects. Patients are advised to avoid smoking while taking this medication.

Given the complexity of hormone therapy and potential drug interactions, it is crucial for prescribers to review all medications, including over-the-counter drugs and supplements, that a patient is taking before prescribing Estradiol/Estriol Slow Release Capsules. Patients should be advised to report any new medications or changes in their health status to their healthcare provider. If you have any questions or require further information regarding drug interactions with this formulation, please reach out to us at Bayview Pharmacy for assistance.

How Does it Work

A small arrow pointing down

The Estradiol 0.2 mg/Estriol 0.8 mg Slow Release (MEM4) Oral Capsules are a specialized hormone replacement therapy (HRT) designed to alleviate symptoms associated with menopause and other conditions that result from estrogen deficiency. This formulation combines two forms of estrogen: estradiol, the primary and most potent naturally occurring human estrogen, and estriol, a weaker estrogen that is abundant during pregnancy. The ratio of estradiol to estriol in this formulation is optimized to provide a balanced effect, with estradiol addressing the more severe symptoms of estrogen deficiency and estriol offering a gentler, more protective estrogenic effect.

The unique aspect of these capsules is the incorporation of Methocel E4M, a hydrophilic methylcellulose derivative. Methocel E4M is a high-viscosity grade of hypromellose, which is widely used in pharmaceutical formulations as a controlled-release agent. When the capsule is ingested and comes into contact with gastric fluids, Methocel E4M forms a gel-like matrix that encapsulates the active hormones. This matrix swells and provides a barrier to the immediate release of the hormones, thereby controlling the rate at which they are released into the bloodstream.

The slow dissolution of the Methocel E4M matrix in the digestive tract allows for a gradual and sustained release of estradiol and estriol. This controlled-release mechanism ensures a steady state of hormone levels over an extended period, which can help in maintaining symptom relief without the peaks and troughs associated with immediate-release formulations. By mimicking the body's natural rhythm of hormone release, these capsules can help in reducing the frequency of dosing, which in turn can improve patient compliance and overall treatment satisfaction.

This formulation is particularly beneficial for patients experiencing menopausal symptoms such as hot flashes, night sweats, vaginal dryness, and mood swings. It can also be used in managing other conditions that are a result of low estrogen levels, such as osteoporosis and certain menstrual disorders. The slow release of hormones also means that the formulation is less likely to cause side effects that can occur with higher, fluctuating levels of hormones, thus providing a more consistent and well-tolerated HRT option.

It is important for patients and prescribers to understand that while this formulation offers many benefits, it should be used under the guidance of a healthcare professional who can monitor hormone levels and adjust dosing as necessary. If you have any questions about the Estradiol 0.2 mg/Estriol 0.8 mg Slow Release (MEM4) Oral Capsules or would like to know more about how this formulation can be integrated into a patient's treatment plan, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide the support and information you need to ensure the safe and effective use of this medication.

Other Uses

A small arrow pointing down

Please note that as compounding pharmacists, we must emphasize the importance of using compounded medications as prescribed by a healthcare provider and adhering to regulatory guidelines. This Estradiol 0.2 mg/Estriol 0.8 mg slow-release oral capsule formulation is typically prescribed for hormone replacement therapy to ease symptoms associated with menopause such as hot flashes, night sweats, vaginal dryness, osteoporosis prevention, and certain cases of hormone imbalance. However, the customizability of compounded medications allows for its potential use in other applications as directed by a healthcare provider.

Though traditionally used for menopause-related symptoms, the balanced combination of estradiol and estriol could be considered for other off-label uses where estrogen therapy is indicated. This might include assistance in managing symptoms related to premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD), as well as the potential management of certain skin conditions that respond to hormone therapy. Due to the combination of these two estrogens in a slow-release formulation, some patients might experience benefits in terms of steady hormonal support.

Additionally, patients dealing with certain hormonal deficiencies or gonadal dysgenesis may find this formulation appropriate when a continuous, controlled dose of estrogen is desired. Some prescribers may also consider the formulation for transgender hormone therapy as part of a gender-affirming treatment plan. Nevertheless, it is crucial to assess the risks, benefits, and individual patient factors when contemplating any hormone therapy use. Monitoring by a healthcare provider is essential for any off-label application to ensure safe and effective use.

Another potential but less common use of this formulation could be related to its neuroprotective effects, as studies have suggested that estradiol and estriol may exert protective mechanisms in the brain; however, such applications would be highly experimental and require careful consideration and monitoring by healthcare professionals.

It is important to bear in mind that because compounding allows for customization, each capsule's dosage and release characteristics can be tailored to individual patient needs, which is particularly beneficial for patients who may have allergies or sensitivities to certain ingredients in commercially available medications. Always consult with a healthcare provider before starting any new treatment. If you have any questions about these uses or whether our compounded estradiol/estriol formulation may be right for you, please reach out to us at Bayview Pharmacy for more information.

Frequently Asked Questions

A small arrow pointing down

What are Estradiol 0.2 mg/Estriol 0.8 mg Slow Release (MEM4) Oral Capsules used for?

Estradiol/Estriol slow release capsules are used for hormone replacement therapy (HRT), particularly in postmenopausal women. They help alleviate symptoms associated with estrogen deficiency such as hot flashes, vaginal dryness, and osteoporosis prevention.

How do the slow release capsules work?

The capsules are formulated with Methocel E4M, a controlled-release polymer that allows the medication to be released gradually over an extended period. This provides sustained therapeutic effects and reduces the need for frequent dosing.

What is Methocel E4M and why is it used in these capsules?

Methocel E4M is a type of hydrophilic polymer used in pharmaceutical formulations to control the release rate of the medication. It is used in these capsules to ensure a consistent and prolonged delivery of the hormones into the bloodstream.

What are the benefits of using a slow release formulation for hormone therapy?

A slow release formulation offers several benefits, such as minimized fluctuations in hormone levels, fewer side effects, improved patient compliance, and a more convenient dosing schedule.

How often do I need to take Estradiol/Estriol slow release capsules?

The dosing frequency can vary depending on individual treatment plans, but the slow-release formulation is typically designed to be taken once daily. Always follow your healthcare provider’s instructions regarding dosage.

Can I take Estradiol/Estriol slow release capsules with food?

Yes, you can take these capsules with or without food. However, it's important to take them at the same time each day to maintain consistent hormone levels in your body.

What should I do if I miss a dose of Estradiol/Estriol slow release capsules?

If you miss a dose, take it as soon as you remember. If it’s almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double up to make up for a missed dose.

Are there any side effects associated with Estradiol 0.2 mg/Estriol 0.8 mg Slow Release Capsules?

As with all medications, there can be side effects. Common side effects include breast tenderness, nausea, headache, and bloating. If you experience any severe side effects or signs of an allergic reaction, seek medical attention immediately.

Is it safe to use Estradiol/Estriol slow release capsules during pregnancy?

No, these capsules should not be used during pregnancy. They are intended for hormone replacement therapy in postmenopausal women and not indicated for use during pregnancy.

Do Estradiol/Estriol capsules interact with other medications?

Yes, Estradiol/Estriol may interact with other medications. It’s important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements, to avoid potential drug interactions.

How should I store Estradiol/Estriol slow release capsules?

Store the capsules at room temperature, away from moisture, heat, and direct light. Keep the capsules out of reach of children and pets.

Related Formulas

Related Products
Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
NEW PRESCRIPTION ORDER FORM
1
Circle for steps.
Patient Information
2
Circle for steps.
Prescriber and Prescription Information
3
Circle for steps.
Fax order form to Bayview Pharmacy at 401-284-4506.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.